Haleon PLC has seen significant investment including a new $569,000 investment from Ascent Group LLC and increased stock positions by Millennium Management LLC and others. Increased shares were also purchased by firms such as Baird Financial Group Inc., Jane Street Group LLC, and Northwestern Mutual Wealth Management Co.
Goldman Sachs upgraded Haleon stock to Buy due to expected growth acceleration. The company has additionally advanced its share buyback program, recently completing multiple share buybacks and executing additional buyback transactions. Despite a recent fall on cut organic revenue guidance, analysts believe a U-turn is imminent due to US recovery. Notably, a £10,000 investment in Haleon shares one year ago would be significantly more valuable today. In another strategic move,
Pfizer sold off its final Haleon shares for $3.2 billion, marking the end of its stake in the consumer healthcare giant. Nevertheless, as we move into the second half of 2025, Haleon anticipates a skewed revenue growth as it completes significant share buybacks including a recent share buyback program tranche despite the sale of stocks to Pfizer.
Haleon Stocks News Analytics from Wed, 15 Jan 2025 08:00:00 GMT to Sat, 13 Sep 2025 10:18:45 GMT -
Rating 8
- Innovation 5
- Information 7
- Rumor -3
